Every day, the liver produces approximately 600–800ml of bile — a complex fluid containing bile acids, cholesterol, phospholipids, bilirubin, and a range of conjugated toxins and metabolic waste products awaiting excretion. The gallbladder concentrates and stores this bile between meals, releasing it into the duodenum in a pulse when fat arrives from the stomach — triggered by cholecystokinin (CCK), the satiety hormone released when dietary fat is detected.
What happens at the moment of release is more complex and more consequential than the standard fat emulsification story suggests. Bile acids do emulsify fat — but they also activate nuclear receptors (FXR, TGR5) in the intestinal wall and liver that regulate lipid metabolism, glucose homeostasis, inflammation, and even thyroid hormone activity. They exert antimicrobial effects that control which bacteria survive in the small intestine. And they carry with them the conjugated end-products of Phase II liver detoxification — the way the body excretes hormones, environmental toxins, and metabolic waste that the liver has rendered water-soluble for removal.
Biliary stasis — inadequate bile flow — is therefore not just a digestive problem. It is a problem with fat absorption, fat-soluble vitamin absorption, hormone excretion, toxin elimination, microbiome regulation, and metabolic signalling simultaneously.
What bile actually does — the complete picture
The Functions of Bile — Beyond Fat Emulsification
Fat emulsification
The primary textbook function. Bile acids are amphipathic — they have water-soluble and fat-soluble ends — and this structure allows them to break large fat globules into small micelles that lipase enzymes can access. Without adequate bile, fats are not adequately broken down and pass through to the colon unabsorbed, producing characteristic pale, floating, or greasy stools (steatorrhoea).
Fat-soluble vitamin absorption
Vitamins A, D, E, and K are fat-soluble — they require the same micelle formation that fat absorption requires. Without adequate bile flow, fat-soluble vitamins are not absorbed regardless of dietary intake or supplementation. The person taking vitamin D3 but remaining deficient may have biliary insufficiency as the upstream cause of the supplementation failure. The same applies to vitamin K2 (critical for calcium direction) and vitamin E (the primary lipid-phase antioxidant).
Liver detoxification excretion
Phase II liver detoxification converts fat-soluble toxins, hormones, and metabolic waste into water-soluble conjugates (glucuronidates, sulphates, glycine conjugates, glutathione conjugates) that are then excreted into bile for removal via the gut. This is the primary excretion route for: oestrogen metabolites, heavy metals (methylmercury), environmental toxins (PCBs, pesticides, BPA), drug metabolites, and bilirubin. When bile flow is sluggish, conjugated toxins that should be excreted are reabsorbed rather than eliminated.
Oestrogen recirculation
Conjugated oestrogens excreted in bile are, under normal circumstances, further metabolised by gut bacteria (using the enzyme beta-glucuronidase) and then reabsorbed in a process called enterohepatic circulation. The balance between excretion and reabsorption determines circulating oestrogen levels. Biliary stasis reduces the excretion side of this equation. Gut dysbiosis with elevated beta-glucuronidase (measurable on GI-MAP) increases the reabsorption side. Both drive oestrogen excess — independently and in combination. This is the hepato-biliary-gut mechanism underlying oestrogen dominance in many women.
Microbiome regulation
Bile acids are potent antimicrobials — they disrupt bacterial cell membranes and are the primary mechanism controlling bacterial populations in the small intestine. Insufficient bile acid concentration in the small intestine allows bacterial overgrowth — one of the primary mechanisms driving SIBO. Bacteria that deconjugate bile acids (including many pathobionts) further reduce the antimicrobial efficacy of the bile pool, creating a vicious cycle.
Metabolic signalling via FXR and TGR5
Bile acids activate two major nuclear receptors. FXR (Farnesoid X Receptor) in the liver and intestine regulates triglyceride synthesis, glucose homeostasis, and intestinal barrier integrity. TGR5 (a G-protein coupled receptor) in enteroendocrine cells stimulates GLP-1 release — the same satiety hormone mimicked by Ozempic — and in skeletal muscle and brown adipose tissue increases mitochondrial activity and thermogenesis. Adequate bile acid signalling is a functional driver of metabolic health that is entirely absent from standard metabolic assessment.
Cholesterol excretion
The liver converts cholesterol into bile acids as a primary route of cholesterol disposal. Impaired bile flow reduces this conversion — contributing to elevated cholesterol in some presentations. The relationship between bile acid metabolism, cholesterol, and cardiovascular risk is more complex than the LDL narrative — but bile acid excretion is a direct and underappreciated pathway for cholesterol clearance.
The gallbladder — the function beyond storage
The gallbladder is not a passive storage vessel. It concentrates bile approximately 10-fold by actively removing water and electrolytes, producing a highly concentrated bile that delivers a potent antimicrobial and emulsification pulse to the duodenum when fat is eaten. The CCK-mediated contraction of the gallbladder is also a critical satiety signal — gallbladder contraction is part of the hormonal cascade signalling fullness after a fat-containing meal.
People who have had their gallbladder removed (cholecystectomy) — approximately 70,000 procedures annually in the UK — do not stop making bile. The liver continues to produce it continuously, but without the storage and concentration function of the gallbladder, bile trickles continuously into the duodenum rather than arriving in a concentrated pulse when fat is eaten. This means the bile acid concentration at the moment of fat arrival is significantly lower — impairing fat emulsification, fat-soluble vitamin absorption, and the CCK satiety signalling that depended on gallbladder contraction.
Post-cholecystectomy syndrome — the cluster of ongoing digestive symptoms after gallbladder removal — is partly explained by this mechanism, alongside changes in gut motility and microbiome composition that follow the altered bile acid profile.
Biliary stasis — far more common than gallstones
Gallstones affect approximately 10–15% of the UK population. Biliary sludge — the intermediate state between normal bile and stones — is more common still and often clinically silent. But the broader category of biliary stasis — sluggish bile flow without overt structural disease — is the most clinically relevant and the least assessed.
Biliary stasis can exist with a structurally normal gallbladder and without gallstones. The bile is simply flowing poorly — too viscous, too poorly stimulated by CCK, produced in insufficient quantity, or impaired in its enterohepatic circulation by gut dysbiosis. The functional consequences are identical to more advanced biliary disease: fat malabsorption, fat-soluble vitamin deficiency, impaired toxin excretion, SIBO predisposition, and oestrogen recirculation.
Signs and symptoms of compromised bile flow
Digestive symptoms
Pale, floating, or fatty stools (steatorrhoea) · Bloating and distension after fat-containing meals · Nausea especially with fatty or rich foods · Right upper quadrant discomfort or fullness after eating · Inability to tolerate dietary fat
Nutritional consequences
Persistent vitamin D deficiency despite supplementation · Vitamin K deficiency (bruising, poor calcium utilisation) · Vitamin A deficiency (night blindness, immune impairment) · Vitamin E deficiency (oxidative stress, neuropathy) · Essential fatty acid deficiency
Hormonal and detoxification
Oestrogen dominance symptoms (PMS, fibroids, weight gain) · Chemical sensitivities and poor toxin tolerance · Elevated liver enzymes (GGT in particular) · Skin conditions (acne, eczema, psoriasis) from impaired toxin excretion
Gut-related consequences
SIBO (from reduced antimicrobial bile acids in small intestine) · Bacterial dysbiosis · Loose stools from deconjugated bile acids reaching the colon · Elevated beta-glucuronidase on GI-MAP (reflecting dysbiotic oestrogen recirculation)
What drives biliary stasis — the root causes
Low dietary fat intake is paradoxically one of the most common causes of biliary stasis — the gallbladder is only stimulated to contract when CCK detects fat in the duodenum. A very low-fat diet means the gallbladder sits unstimulated for long periods, bile stagnates, and the risk of sludge and stone formation increases. This is the clinical reason why very low-fat diets — particularly when sustained for years — increase gallstone risk despite the apparently sensible caloric logic.
Low stomach acid (hypochlorhydria) impairs CCK release — CCK is released partly in response to the pH drop that occurs when acidic chyme from the stomach enters the duodenum. Low HCl → inadequate pH drop → reduced CCK stimulus → impaired gallbladder contraction. This is the mechanism connecting PPI use and proton pump inhibitor-induced gut dysbiosis to biliary stasis.
Oestrogen is the most powerful driver of bile viscosity — it increases the cholesterol saturation of bile. This is why gallstone prevalence is higher in women, increases during pregnancy, and is associated with oral contraceptive use and HRT. Obesity increases oestrogen production from adipose tissue, compounding this effect.
How we see biliary insufficiency on functional testing
OAT: Elevated suberic acid (C8 dicarboxylic acid) and adipic acid — fat malabsorption markers that accumulate when dietary fat cannot be emulsified and absorbed normally. These organic acid markers are often the first functional indication of biliary insufficiency in an otherwise normal-appearing picture.
GI-MAP: Elevated beta-glucuronidase — the bacterial enzyme that deconjugates oestrogen in the gut, increasing recirculation. Steatocrit (fat in stool). Pancreatic elastase as a confound differentiator (is the fat malabsorption biliary or pancreatic?). Dysbiosis pattern consistent with SIBO predisposition.
Blood chemistry: Elevated GGT (most sensitive liver marker — elevated in bile duct stress, oxidative load, and alcohol) · Low total cholesterol (the liver cannot convert cholesterol to bile acids adequately) · Elevated alkaline phosphatase (ALP — bile duct enzyme) · Fat-soluble vitamin levels.
Clinical support for bile flow
Bile Flow Support — Clinical Protocol
Dietary fat
Ensure adequate fat intake at every meal — minimum 15–20g per meal to stimulate adequate CCK and gallbladder contraction. Avocado, olive oil, nuts, eggs, oily fish. This is counter-intuitive for many patients who have been told to avoid fat because of gallbladder symptoms — but inadequate fat worsens stasis long-term.
Bitters
Digestive bitters (dandelion root, artichoke leaf, gentian, milk thistle combination) taken 15–20 minutes before meals stimulate bile acid production via the bitter taste receptor pathway. The most evidence-based approach for functional biliary insufficiency. Artichoke extract 320–640mg per meal is the best-studied single agent.
Ox bile
Exogenous bile acids from bovine bile — directly replaces the bile acids the body is not adequately producing or concentrating. 125–500mg with each fat-containing meal. Particularly important post-cholecystectomy and in those with confirmed fat malabsorption markers. Should be dosed to effect — too much produces loose stools (bile acid diarrhoea), the correct dose produces normal fat-containing stools.
Phosphatidylcholine
The primary phospholipid in bile — 840mg as sunflower lecithin improves bile composition and fluidity. Also directly supports hepatocyte membrane integrity and VLDL secretion. Addresses the bile composition problem rather than just the flow problem.
TUDCA
Tauroursodeoxycholic acid — a bile acid with hepatoprotective and choleretic (bile-stimulating) properties. 250–500mg daily. Directly stimulates bile acid synthesis and flow. Also used as a hepatoprotective agent in liver disease and increasingly for neurological protection (TUDCA is neuroprotective and is being investigated in ALS and Parkinson's).
Milk thistle
Silymarin (standardised milk thistle extract) 140–200mg three times daily. Primarily hepatoprotective — supports hepatocyte bile acid synthesis and protects liver cells from the oxidative damage of biliary stasis. Does not directly stimulate flow but addresses the liver-level impairment that often underlies inadequate bile production.
Betaine HCl
Addressing underlying hypochlorhydria is often the prerequisite for adequate CCK release and gallbladder contraction. Betaine HCl at meals — dose titrated upward until slight warmth is felt, then reducing by one capsule — restores the gastric acid stimulus that drives the CCK-gallbladder contraction cascade. Address the root before supplementing the consequence.
The person who cannot tolerate fatty food, whose vitamin D doesn't rise despite supplementation, who has oestrogen dominance symptoms, whose OAT shows fat malabsorption markers, and who has persistent SIBO may have a single upstream driver: impaired bile flow. The gallbladder scan is normal. The liver enzymes are "fine." The functional picture is telling a different story.
Seeing fat malabsorption or oestrogen-related symptoms?
The OAT reveals the fat malabsorption organic acid pattern. The GI-MAP maps beta-glucuronidase and gut dysbiosis driving recirculation. Together they provide the functional bile picture that standard blood tests miss.
Talk to the Concierge
Related reading